PTPI News and Press, Petros Pharmaceuticals Inc.

A look at the top 10 most actives in the United States Sharps Technology Inc. (STSS) rose 39.8% to $0.4185 on volume of 56,031,365 shares Nuburu Inc. (BURU) fell 36.1% to $0.0933 on volume of 49,471,677 shares BioRestorative Therapies Inc (BRTX) rose 66.7% to $2.25 on volume of 46,968,012...

Study paves the way toward a first-ever innovation program to include AI-optimization for FDA-guided Rx-to-OTC switch NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medicati...

Team composed of former FDA officials and key clinical and regulatory opinion leaders to help provide insight in preparation for collaboration with FDA NEW YORK, NY / ACCESSWIRE / May 21, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to med...

2024-05-16 10:53:35 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Petros Pharmaceuticals (NASDAQ: PTPI ) just reported results for the first quarter of 2024. Petros Pharmaceuticals reported earnings per share of -$1.69. This was below th...

Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 minutes prior to sexual activity (100mg and 200mg strengths only) [1] Please see Important Safety Information and study design below NEW YORK, NY / ACCESSWIRE ...

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Lemonaid Health, Inc., a subsidiary of 23andMe Holding Co., (Nasdaq: ME), and a leading telemedicine provider, is now offering Petros Pharmaceuticals, Inc.’s (Nasdaq: PTPI), prescription erectile dysfunction (ED) medication STENDRA ...

2024-05-03 17:43:06 ET More on Petros Pharmaceuticals Seeking Alpha’s Quant Rating on Petros Pharmaceuticals Historical earnings data for Petros Pharmaceuticals Financial information for Petros Pharmaceuticals Read the full article on Seeking Alpha ...

--News Direct-- Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, highlighting a new collaboration with Lemonaid Health, a prominent telemedicine provider and subsidiary of 23andMe. Through this collaboration, Lemonai...

Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED patients (Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a company focused on ...

(Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Petros Pharmaceuticals, Inc. ("Petros," or the "Company") (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug development programs, announ...